New-onset diabetes | Univariate analysis | Multivariate analysis | |||
---|---|---|---|---|---|
No | Yes | HR (95% CI) | P value | HR (95% CI) | |
Number | 60,173 (97.7%) | 1414 (2.3%) | |||
Sex | |||||
Men (%) | 26,573 (97.7%) | 638 (2.3%) | 1.00 | 0.428 | |
Women (%) | 33,600 (97.7%) | 776 (2.3%) | 0.96 (0.86–1.06) | ||
Age (years) | 67.68 ± 6.09 | 66.98 ± 5.90 | 0.98 (0.97–0.99) | < 0.001 | |
60–70 | 40,415 (97.6%) | 1013 (2.4%) | 1.00 | 0.002 | 1.00* |
71–80 | 16,749 (98.0%) | 344 (2.0%) | 0.83 (0.73–0.93) | 0.82 (0.72–0.92) | |
> 80 | 3009 (98.1%) | 57 (1.9%) | 0.76 (0.58–1.00) | 0.75 0.58–0.99) | |
Hypertension | |||||
No (%) | 26,811 (97.9%) | 577 (2.1%) | 1.00 | 0.008 | |
Yes (%) | 33,362 (97.6%) | 837 (2.4%) | 1.15 (1.04–1.28) | ||
SBP (mmHg) | 127.47 ± 13.51 | 127.44 ± 12.56 | 1.00 (0.99–1.00) | 0.641 | |
< 120 | 16,261 (97.8%) | 359 (2.2%) | 1.00 | 0.016 | |
120–139 | 36,026 (97.6%) | 896 (2.4%) | 1.11 (0.98–1.25) | ||
≥ 140 | 7886 (98.0%) | 159 (2.0%) | 0.88 (0.73–1.06) | ||
DBP (mmHg) | 78.71 ± 7.63 | 78.51 ± 7.05 | 1.00 (0.99–1.00) | 0.202 | |
< 80 | 28,102 (97.7%) | 667 (2.3%) | 1.00 | 0.026 | |
80–89 | 26,782 (97.6%) | 649 (2.4%) | 1.01 (0.91–1.12) | ||
≥ 90 | 5289 (98.2%) | 98 (1.8%) | 0.76 (0.61–0.94) | ||
BMI (kg/m2) | 24.66 ± 3.08 | 25.56 ± 3.19 | 1.09 (1.07–1.11) | < 0.001 | |
< 18.5 | 811 (99.1%) | 7 (0.9%) | 0.48 (0.23–1.00) | < 0.001 | 0.48 (0.23–1.02) |
18.5–23.9 | 26,577 (98.2%) | 479 (1.8%) | 1.00 | 1.00* | |
24–27.9 | 24,622 (97.5%) | 641 (2.5%) | 1.43 (1.27–1.61) | 1.28 (1.14–1.45) | |
≥ 28 | 8163 (96.6%) | 287 (3.4%) | 1.91 (1.65–2.21) | 1.48 (1.28–1.72) | |
WC (cm) | 84.94 ± 8.54 | 87.01 ± 9.15 | 1.03 (1.02–1.03) | < 0.001 | |
< 85 (Women)/ < 90 (Men) | 37,389 (98.0%) | 748 (2.0%) | 1.00 | < 0.001 | |
≥ 85 (Women)/ ≥ 90 (Men) | 22,784 (97.2%) | 666 (2.8%) | 1.44 (1.30–1.60) | ||
TC (mmol/L) | 5.24 ± 1.12 | 5.24 ± 1.32 | 0.99 (0.95–1.04) | 0.993 | |
< 5.2 | 30,436 (97.6%) | 746 (2.4%) | 1.00 | 0.083 | |
≥ 5.2 | 29,737 (97.8%) | 668 (2.2%) | 0.91 (0.82–1.01) | ||
TG (mmol/L) | 1.54 ± 0.95 | 1.72 ± 1.07 | 1.12 (1.09–1.16) | < 0.001 | |
< 1.7 | 43,392 (97.9%) | 929 (2.1%) | 1.00 | < 0.001 | |
≥ 1.7 | 16,781 (97.2%) | 485 (2.8%) | 1.33 (1.19–1.48) | ||
FBG (mmol/L) | 5.35 ± 0.91 | 5.96 ± 1.35 | 1.08 (1.07–1.09) | < 0.001 | |
< 6.1 | 52,939 (98.3%) | 911 (1.7%) | 1.00 | < 0.001 | 1.00* |
6.1–6.9 | 5819 (95.2%) | 294 (4.8%) | 2.82 (2.47–3.22) | 2.75 (2.40–3.14) | |
≥ 7.0 | 1415 (87.1%) | 209 (12.9%) | 7.85 (6.75–9.13) | 7.34 (6.29–8.56) | |
ALT (U/L) | 21.72 ± 14.67 | 24.74 ± 14.71 | 1.01 (1.00–1.01) | < 0.001 | |
< 40 | 56,788 (97.8%) | 1266 (2.2%) | 1.00 | < 0.001 | 1.00* |
≥ 40 | 3385 (95.8%) | 148 (4.2%) | 1.90 (1.60–2.25) | 1.42 (1.20–1.70) | |
AST (U/L) | 23.62 ± 12.17 | 24.67 ± 11.11 | 1.00 (1.00–1.01) | 0.003 | |
< 45 | 58,603 (97.8%) | 1348 (2.2%) | 1.00 | < 0.001 | |
≥ 45 | 1570 (96.0%) | 66 (4.0%) | 1.76 (1.38–2.26) | ||
TBIL (µmol/L) | 13.91 ± 6.02 | 13.49 ± 5.74 | 0.99 (0.98–1.00) | 0.007 | |
< 20 | 53,499 (97.7%) | 1286 (2.3%) | 1.00 | 0.008 | 1.00* |
≥ 20 | 6674 (98.1%) | 128 (1.9%) | 0.78 (0.65–0.94) | 0.70 (0.58–0.84) | |
Scr (µmol/L) | 75.60 ± 22.05 | 75.89 ± 19.40 | 1.00 (1.00–1.01) | 0.705 | |
< 106 | 56,698 (97.7%) | 1332 (2.3%) | 1.00 | 0.976 | |
≥ 106 | 3475 (97.7%) | 82 (2.3%) | 1.00 (0.80–1.25) | ||
BUN (mmol/L) | 5.66 ± 2.00 | 5.59 ± 1.89 | 0.98 (0.96–1.01) | 0.236 | |
< 7.1 | 51,425 (97.6%) | 1243 (2.4%) | 1.00 | 0.007 | |
≥ 7.1 | 8748 (98.1%) | 171 (1.9%) | 0.80 (0.68–0.94) | ||
Hgb (g/L) | 138.76 ± 15.11 | 139.32 ± 16.04 | 1.00 (1.00–1.01) | 0.268 | |
< 110 (Women)/ < 120 (Men) | 1663 (97.7%) | 39 (2.3%) | 1.02 (0.74–1.41) | 0.888 | |
≥ 110 (Women)/≥120 (Men) | 58,510 (97.7%) | 1375 (2.3%) | 1.00 | ||
WBC (*1012/L) | 6.02 ± 3.96 | 6.21 ± 3.56 | 1.01 (1.00–1.02) | 0.073 | |
< 4.0 | 3464 (98.7%) | 45 (1.3%) | 0.54 (0.40–0.72) | < 0.001 | |
4.0–9.9 | 55,856 (97.6%) | 1349 (2.4%) | 1.00 | ||
≥ 10 | 853 (97.7%) | 20 (2.3%) | 0.98 (0.63–1.53) | ||
PLT (*1012/L) | 209.57 ± 55.85 | 209.24 ± 53.14 | 1.00 (1.00–1.00) | 0.747 | |
< 100 | 56,174 (97.7%) | 1328 (2.3%) | 1.55 (1.06–2.27) | 0.007 | |
100–299 | 726 (96.4%) | 27 (3.6%) | 1.00 | ||
≥ 300 | 3273 (98.2%) | 59 (1.8%) | 0.76 (0.58–0.98) | ||
Smoking status | |||||
Never | 45,412 (75.5%) | 1132 (80.1%) | 1.00 | < 0.001 | |
Past | 2816 (4.7%) | 58 (4.1%) | 0.82 (0.63–1.06) | ||
Current | 11,945 (19.9%) | 224 (15.8%) | 0.74 (0.64–0.85) | ||
Alcohol consumption | |||||
Never | 50,475 (83.9%) | 1242 (87.8%) | 1.00 | 0.001 | 1.00* |
Less than once a week | 4363 (7.3%) | 77 (5.4%) | 0.71 (0.57–0.90) | 0.67 (0.53–0.84) | |
More than once a week | 1507 (2.5%) | 30 (2.1%) | 0.80 (0.56–1.15) | 0.70 (0.49–1.01) | |
Everyday | 3828 (6.4%) | 65 (4.6%) | 0.69 (0.54–0.88) | 0.66 (0.51–0.85) | |
Diet | |||||
Animal-based | 732 (1.2%) | 16 (1.1%) | 1.00 | 0.828 | |
Balanced | 57,227 (95.1%) | 1349 (95.4%) | 1.08 (0.66–1.78) | ||
Vegetarian diet | 2214 (3.7%) | 49 (3.5%) | 1.00 (0.57–1.76) | ||
Physical activity | |||||
Never | 12,706 (21.1%) | 307 (21.7%) | 1.00 | 0.676 | |
Less than once a Week | 3193 (5.3%) | 82 (5.8%) | 1.06 (0.83–1.35) | ||
More than once a week | 13,467 (22.4%) | 304 (21.5%) | 0.93 (0.79–1.09) | ||
Everyday | 30,807 (51.2%) | 721 (51.0%) | 0.98 (0.85–1.12) | ||
History of drug use | |||||
Statins | |||||
No (%) | 59,856 (97.7%) | 1401 (2.3%) | 1.00 | 0.046 | 1.00** |
Yes (%) | 317 (96.1%) | 13 (3.9%) | 1.74 (1.01–3.01) | 1.85 (1.07–3.20) | |
Psychotropics | |||||
No (%) | 60,018 (97.7%) | 1410 (2.3%) | 1.00 | 0.752 | |
Yes (%) | 155 (97.5%) | 4 (2.5%) | 1.17 (0.44–3.13) |